ACKNOWLEDGMENT: “This project has received funding from the European Union’s H2020-MSCA-RISE-2015 under grant agreement No 691247”.

Beneficiary 8 - Proteos

General Description: Proteos Biotech possesses laboratories dedicated to in vitro studies where develops safety

evaluation report, stability assays, biocompatibility assays, efficacy assays and clinical safety assays. The

facilities of Proteos, located in Madrid and Albacete are equipped with the last technology to carry out all

studies. All activities performed in Proteos are under a QMS and GLP. Highly qualified employees, owing

PhD or master degrees in biology, chemistry or finance consist the scientific team of the company.